Results 81 to 90 of about 4,088,174 (172)

NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery

open access: yesFrontiers in Oncology, 2020
PurposeTo assess stereotactic radiotherapy (SRT)/stereotactic body radiotherapy (SBRT) practices by polling clinics participating in multi-institutional clinical trials.MethodsThe NRG Oncology Medical Physics Subcommittee distributed a survey consisting ...
Mikhail Chetvertkov   +12 more
doaj   +1 more source

Boron‐embedded multifunctional nanoplatform toward potential combined boron neutron capture therapy and immunomodulation in glioma

open access: yesSmart Molecules, EarlyView.
A brain‐targeting multifunctional nanoplatform (DM&Ce6@COF‐Ang) was engineered by employing boron‐enriched APTES‐COF‐1 as both the therapeutic boron agent and the nanocarrier co‐delivery of DMXAA and Ce6. This nanoplatform achieved synergistic tumor‐specific boron delivery, real‐time pharmacokinetic monitoring, and immunomodulation.
Yiming Liu   +13 more
wiley   +1 more source

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives

open access: yes, 2015
James E Neffendorf, Timothy L Jackson Department of Ophthalmology, School of Medicine, King’s College London, London, United Kingdom Abstract: Neovascular age-related macular degeneration is a leading cause of blindness in the developed world ...
Jackson TL, Neffendorf JE
core  

Interventional Radiology Society of Australasia Quality Care Guidelines for Renal Tumour Ablation in Australia and New Zealand

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Image‐guided thermal ablation (radiofrequency, cryo‐ and microwave ablation) is a safe and effective primary treatment for small renal mass and localised renal cell carcinoma ≤ 4 cm (T1a) with long‐term cancer‐specific survival rates equivalent to surgical resection (Level A).
Matthew Lukies   +6 more
wiley   +1 more source

Adoption of Hypofractionated Radiation Therapy and Quality of Life Outcomes for Localised Prostate Cancer in an Australian Population‐Based Cohort

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Objectives We aimed to evaluate the adoption of hypofractionated radiotherapy (HFRT) for localised prostate cancer (PCa) and the quality of life (QOL) outcomes at a population‐based level in Victoria. Methods This is a population‐based cohort of individuals with PCa registered in the Victorian Prostate Cancer Outcomes Registry (PCOR‐Vic) who ...
Therese Min Jung Kang   +13 more
wiley   +1 more source

Management of Pulmonary Oligometastases by Stereotactic Body Radiotherapy

open access: yes, 2014
Aims and Background The aim of the study was to evaluate the feasibility, toxicity and effectiveness of active breathing control-guided stereotactic body radiotherapy in the management of pulmonary oligometastases.
Bahar Dirican   +8 more
core   +1 more source

Challenges in imaging assessment following liver stereotactic body radiotherapy: pitfalls to avoid in clinical practice [PDF]

open access: yes, 2017
Stereotactic body radiotherapy (SBRT) is increasingly used in the management of unresectable liver metastases and hepatocellular carcinoma (HCC) as it allows delivery of high-dose conformal radiotherapy with limited toxicities.
Kasia Owczarczyk   +7 more
core   +1 more source

Safety and Efficacy of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors Using a Risk-optimized Fractionation Scheme

open access: yes, 2021
Delivery of stereotactic body radiotherapy (SBRT) to ultracentral lung tumors remains a major challenge, with potentially excessive SBRT-related toxicity.
Regnery, Sebastian   +23 more
core   +1 more source

Linear Accelerator–Based Stereotactic Body Radiotherapy of 36.25 Gy in Five Fractions for Localised Prostate Cancer: A Retrospective Single‐Institution Cohort Study

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Background Stereotactic body radiotherapy has become an established treatment option for localised prostate cancer. However, real‐world evidence from routine clinical practice remains limited, particularly in cohorts that include older patients.
Atsuto Katano, Hideomi Yamashita
wiley   +1 more source

sj-tif-6-dos-10.1177_15593258211064499 – Supplemental Material for Stereotactic Body Radiotherapy and Conventional Radiotherapy Induce Cytoskeleton Extension and Enlargement of Cell Morphology in Non-Small Cell Lung Cancer

open access: yes, 2021
Supplemental Material, sj-tif-6-dos-10.1177_15593258211064499 for Stereotactic Body Radiotherapy and Conventional Radiotherapy Induce Cytoskeleton Extension and Enlargement of Cell Morphology in Non-Small Cell Lung Cancer by Xiao Wang, Yanwei Lu, Zhiquan
Xiao Wang (19312)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy